Moffitt Cancer Center
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Moffitt Cancer Center, Fulgent Pharma Partner to Advance Personalized Cancer Therapies
Fulgent will have access to Moffitt's expertise and resources to advance its pipeline of nano-particle-based cancer therapies.
Moffitt Cancer Center Starts Trial of Gamma Delta CAR T-Cell Therapy in Advanced Prostate Cancer
Investigators are studying MSGV1-PSCA-8T28Z in a Phase I trial of roughly 30 previously treated patients whose prostate cancers have metastasized to the bone.
Foundation Medicine Monitoring Assays Show Promise for Guiding Lung Cancer Chemo-Immunotherapy
Premium
Investigators showed that patients who are positive for ctDNA at the time of their fourth induction treatment have poorer outcomes and could benefit from new strategies.
LUNGevity, Moffitt Cancer Center to Study Precision Oncology Disparities in Black NSCLC Patients
Premium
With funding from Foundation Medicine, the organizations are trying to systematically understand the reasons why Black patients aren't getting biomarker testing that can enable precision treatment.